 <h1>Pemetrexed Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of pemetrexed include:</b> anemia, chest pain, constipation, depression, desquamation, diarrhea, dyspnea, fatigue, fever, increased serum creatinine, infection without neutropenia, leukopenia, nausea, neuropathy, neutropenia, pharyngitis, skin rash, stomatitis, thrombocytopenia, vomiting, anorexia, and mood changes. <b>Other side effects include:</b> embolism, thrombosis, dehydration, dysphagia, esophagitis, and odynophagia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to pemetrexed: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, pemetrexed may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking pemetrexed:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>fever</li>
<li>loss of coordination</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
<li>pains in the chest, groin, or legs, especially calves of the legs</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>severe headaches of sudden onset</li>
<li>sore throat</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>swollen glands</li>
<li>troubled breathing</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bloody urine or bloody stools</li>
<li>decreased frequency or amount of urine</li>
<li>fainting or loss of consciousness</li>
<li>fast or irregular breathing</li>
<li>increased blood pressure</li>
<li>increased thirst</li>
<li>itching, skin rash</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>swelling of the eyes, eyelids, face, fingers, or lower legs</li>
<li>tightness in the chest</li>
<li>vomiting</li>
<li>weight gain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>joint or muscle pain</li>
<li>pain and redness of the skin in the area of earlier radiation treatment</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>stomach cramps, tenderness, or pain</li>
<li>watery diarrhea</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of pemetrexed may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, tingling, numbness, or pain in the hands, arms, feet, or legs</li>
<li>confusion</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficulty having a bowel movement</li>
<li>difficulty with moving</li>
<li>difficulty with swallowing</li>
<li>discouragement</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>feeling sad or empty</li>
<li>hair loss</li>
<li>headache</li>
<li>heartburn</li>
<li>hoarseness</li>
<li>increase in heart rate</li>
<li>irritability</li>
<li>lightheadedness</li>
<li>loss of interest or pleasure</li>
<li>mood changes</li>
<li>muscle ache, cramp, or stiffness</li>
<li>pain or burning in the throat</li>
<li>pain produced by swallowing</li>
<li>rapid breathing</li>
<li>sensation of pins and needles</li>
<li>stabbing pain</li>
<li>stuffy or runny nose</li>
<li>sunken eyes</li>
<li>swelling or inflammation of the mouth</li>
<li>swollen joints</li>
<li>thinning of the hair</li>
<li>thirst</li>
<li>tiredness</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>weight loss</li>
<li>wrinkled skin</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pemetrexed: intravenous powder for injection</i></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, angina pectoris, cerebrovascular accident, transient ischemic attack, peripheral ischemia (sometimes leading to extremity necrosis), supraventricular arrhythmia, ventricular tachycardia, syncope, arrhythmia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash/desquamation (up to 16%), alopecia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Pruritus, urticaria</p>
<p><b>Rare</b> (less than 0.1%): Radiation recall, bullous conditions (including Stevens-Johnson syndrome and toxic epidermal necrolysis) which in some cases were fatal<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 82%), vomiting (up to 57%), stomatitis/pharyngitis (up to 23%), anorexia (up to 20%), diarrhea (up to 17%), constipation (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Dyspepsia/heartburn</p>
<p><b>Uncommon</b> (0.1% to 1%): Colitis (including intestinal and rectal bleeding, sometimes fatal, intestinal perforation, intestinal necrosis, neutropenic enterocolitis), esophagitis/radiation esophagitis, GI obstruction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (up to 56%), granulocytopenia (up to 56%), leukopenia (up to 53%), hemoglobinemia (up to 26%), platelets decreased (up to 23%), thrombocytopenia (up to 10%)</p>
<p><b>Common</b> (1% to 10%):</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancytopenia</p>
<p><b>Rare</b> (0.01% to 0.1%): Immune mediated hemolytic anemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction/hypersensitivity</p>
<p><b>Rare</b> (0.01% to 0.1%): Anaphylactic shock<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): SGPT (ALT) elevation, SGOT (AST) elevation<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Sepsis (sometimes fatal), infection<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Dehydration</p>
<p><b>Uncommon</b> (0.1% to 1%): Edema, increased gamma-glutamyl transpeptidase (GGT)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Sensory neuropathy (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Taste disturbance</p>
<p><b>Uncommon</b> (0.1% to 1%): Motor neuropathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 48%), pain</p>
<p><b>Common</b> (1% to 10%): Fever, chest pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Depression<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal disorders (including increased serum/blood creatinine, decreased glomerular filtration rate, renal failure, renal/genitourinary- other)</p>
<p><b>Uncommon</b> (0.1% to 1%): Acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Interstitial pneumonitis with respiratory insufficiency (sometimes fatal), radiation pneumonitis, pulmonary embolism<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Alimta (pemetrexed)." Lilly, Eli and Company, Indianapolis, IN. </p><p id="ref_3">3. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p></div>
<div class="more-resources" id="moreResources">
<h2>More about pemetrexed</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: antimetabolites</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Pemetrexed Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Alimta, Pemfexy</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Non-Small Cell Lung Cancer</li>
<li>Malignant Pleural Mesothelioma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pemetrexed: intravenous powder for injection</i></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, angina pectoris, cerebrovascular accident, transient ischemic attack, peripheral ischemia (sometimes leading to extremity necrosis), supraventricular arrhythmia, ventricular tachycardia, syncope, arrhythmia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash/desquamation (up to 16%), alopecia (up to 11%)</p><p><b>Common</b> (1% to 10%): Pruritus, urticaria</p><p><b>Rare</b> (less than 0.1%): Radiation recall, bullous conditions (including Stevens-Johnson syndrome and toxic epidermal necrolysis) which in some cases were fatal<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 82%), vomiting (up to 57%), stomatitis/pharyngitis (up to 23%), anorexia (up to 20%), diarrhea (up to 17%), constipation (up to 12%)</p><p><b>Common</b> (1% to 10%): Dyspepsia/heartburn</p><p><b>Uncommon</b> (0.1% to 1%): Colitis (including intestinal and rectal bleeding, sometimes fatal, intestinal perforation, intestinal necrosis, neutropenic enterocolitis), esophagitis/radiation esophagitis, GI obstruction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (up to 56%), granulocytopenia (up to 56%), leukopenia (up to 53%), hemoglobinemia (up to 26%), platelets decreased (up to 23%), thrombocytopenia (up to 10%)</p><p><b>Common</b> (1% to 10%):</p><p><b>Uncommon</b> (0.1% to 1%): Pancytopenia</p><p><b>Rare</b> (0.01% to 0.1%): Immune mediated hemolytic anemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction/hypersensitivity</p><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic shock<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): SGPT (ALT) elevation, SGOT (AST) elevation<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Sepsis (sometimes fatal), infection<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Dehydration</p><p><b>Uncommon</b> (0.1% to 1%): Edema, increased gamma-glutamyl transpeptidase (GGT)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Sensory neuropathy (up to 10%)</p><p><b>Common</b> (1% to 10%): Taste disturbance</p><p><b>Uncommon</b> (0.1% to 1%): Motor neuropathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 48%), pain</p><p><b>Common</b> (1% to 10%): Fever, chest pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Depression<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal disorders (including increased serum/blood creatinine, decreased glomerular filtration rate, renal failure, renal/genitourinary- other)</p><p><b>Uncommon</b> (0.1% to 1%): Acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Interstitial pneumonitis with respiratory insufficiency (sometimes fatal), radiation pneumonitis, pulmonary embolism<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Alimta (pemetrexed)." Lilly, Eli and Company, Indianapolis, IN. </p><p id="ref_3">3. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><h2>More about pemetrexed</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: antimetabolites</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Pemetrexed Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Non-Small Cell Lung Cancer</li>
<li>Malignant Pleural Mesothelioma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>